Snapshot from Jul 07, 2026 at 01:18 UTC. For live data and tracking: View Live
Entities / Morgan Stanley / Oppenheimer Holdings

Morgan Stanley & Oppenheimer Holdings

2 shared events · Importance 3 · Last updated Jul 03, 2026

Importance
3
Shared Events
2
Actions
0
Sentiment
0
Live sentiment trends, interaction importance charts, and action volume tracking available on the Ergen Dashboard
Shared Events (2)
55
Business
Trevi Therapeutics Prices $150M Offering
Morgan Stanley: Morgan Stanley is acting as a joint book-running manager for Trevi Therapeutics' public offering.
Oppenheimer Holdings: Oppenheimer Holdings is acting as lead manager for Trevi Therapeutics' public offering.
Apr 16, 2026 · 7 articles
30
Business
Analysts Raise JFrog Price Targets
Morgan Stanley: Morgan Stanley raised its price target for JFrog following the company's Q1 earnings.
Oppenheimer Holdings: Oppenheimer called JFrog's full-year guidance conservative, indicating a positive outlook on the company's future performance.
Jun 08, 2026 · 6 articles
NEWSDESK
Explore this relationship live

Track how Morgan Stanley and Oppenheimer Holdings interact across events, view sentiment trends, and discover connected entities.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.